Metformin: From Mechanisms of Action to Therapies - Estadísticas de Google Académico

Artículos que citan Metformin: From Mechanisms of Action to Therapies

Título / Autor	Año
Cancer metabolism: a therapeutic perspective UE Martinez-Outschoorn, M Peiris-Pages, RG Pestell, F Sotgia, ... Nature reviews Clinical oncology 14 (1), 11	2017
Metformin as a tool to target aging N Barzilai, JP Crandall, SB Kritchevsky, MA Espeland Cell metabolism 23 (6), 1060-1065	2016
Autophagy, inflammation, and immunity: a troika governing cancer and its treatment Z Zhong, E Sanchez-Lopez, M Karin Cell 166 (2), 288-298	2016
Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets YK Tham, BC Bernardo, JYY Ooi, KL Weeks, JR McMullen Archives of toxicology 89 (9), 1401-1438	2015
Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications J Zielonka, J Joseph, A Sikora, M Hardy, O Ouari, J Vasquez-Vivar, ... Chemical reviews 117 (15), 10043-10120	2017
AMPK activators: mechanisms of action and physiological activities J Kim, G Yang, Y Kim, J Kim, J Ha Experimental & molecular medicine 48 (4), e224	2016
Global phosphoproteomic analysis of human skeletal muscle reveals a network of exercise-regulated kinases and AMPK substrates NJ Hoffman, BL Parker, R Chaudhuri, KH Fisher-Wellman, M Kleinert, ... Cell metabolism 22 (5), 922-935	2015
Hypothalamic AMPK: a canonical regulator of whole-body energy balance M López, R Nogueiras, M Tena-Sempere, C Diéguez Nature Reviews Endocrinology 12 (7), 421	2016
New mechanisms of metformin action: Focusing on mitochondria and the gut KY Hur, MS Lee Journal of diabetes investigation 6 (6), 600-609	2015
Antidiabetic agents: potential anti-inflammatory activity beyond glucose control AJ Scheen, N Esser, N Paquot Diabetes & metabolism 41 (3), 183-194	2015
Environment dictates dependence on mitochondrial complex I for NAD+ and aspartate production and determines cancer cell sensitivity to metformin DY Gui, LB Sullivan, A Luengo, AM Hosios, LN Bush, N Gitego, ... Cell metabolism 24 (5), 716-727	2016
Targeting hepatic glucose metabolism in the treatment of type 2 diabetes AK Rines, K Sharabi, CDJ Tavares, P Puigserver Nature Reviews Drug Discovery 15 (11), 786	2016
Plk1 inhibitors in cancer therapy: from laboratory to clinics REA Gutteridge, MA Ndiaye, X Liu, N Ahmad Molecular cancer therapeutics 15 (7), 1427-1435	2016
Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity R Romero, O Erez, M Hüttemann, E Maymon, B Panaitescu, ... American journal of obstetrics and gynecology 217 (3), 282-302	2017
Metformin inhibits hepatic mTORC1 signaling via dose-dependent mechanisms involving AMPK and the TSC complex JJ Howell, K Hellberg, M Turner, G Talbott, MJ Kolar, DS Ross, G Hoxhaj, ... Cell metabolism 25 (2), 463-471	2017
Mechanism of metformin: a tale of two sites R Song Diabetes care 39 (2), 187-189	2016
Activation of skeletal muscle AMPK promotes glucose disposal and glucose lowering in non-human primates and mice EC Cokorinos, J Delmore, AR Reyes, B Albuquerque, R Kjøbsted, ... Cell metabolism 25 (5), 1147-1159. e10	2017
Metformin reduces desmoplasia in pancreatic cancer by reprogramming stellate cells and tumor-associated macrophages J Incio, P Suboj, SM Chin, T Vardam-Kaur, H Liu, T Hato, S Babykutty, ... PloS one 10 (12), e0141392	2015
Effects of metformin on metabolite profiles and LDL cholesterol in patients with type 2 diabetes T Xu, S Brandmaier, AC Messias, C Herder, HHM Draisma, A Demirkan, ... Diabetes care 38 (10), 1858-1867	2015
Are metformin doses used in murine cancer models clinically relevant? NS Chandel, D Avizonis, CR Reczek, SE Weinberg, S Menz, R Neuhaus, ... Cell metabolism 23 (4), 569-570	2016

1 - 20

Las fechas y los recuentos de citas son estimados y se determinan de forma automática mediante un programa informático.